The RAPS NC Local Networking Group presents an in-person FDA ASCA Program session focused on the appropriate use of standards, conformity assessment, and practical strategies for premarket submissions. Presented by RAPS in partnership with and sponsored by UL Solutions, the event will feature FDA speakers and provide regulatory, quality, testing, and product development professionals with practical insights into how ASCA works and how it can support more predictable device submissions.
The RAPS NC Local Networking Group is pleased to present an FDA-led discussion on the Accreditation Scheme for Conformity Assessment (ASCA) Program and the broader role of standards in medical device premarket submissions. The session will introduce FDA’s Division of Standards and Conformity Assessment (DSCA), explain how voluntary consensus standards should be used appropriately in premarket submissions, and provide an overview of ASCA, including what it is, how it works, and how it may help manufacturers and FDA reviewers. The program will also cover benefits to manufacturers and FDA, case studies, how to use ASCA to support premarket submissions, what to include in submissions, practical do’s and don’ts, best practices, and next steps for organizations evaluating ASCA. Discussions will also include utilizing eSTAR and a more detailed look at how eSTAR and ASCA fit together in submission planning.
There will be a networking session before the hour-long informational session. Post the session the FDA speakers will answer questions from the audience.
UL Solutions
12 Laboratory Drive
Durham, NC 27713
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


MPM, Regulatory Policy Analyst, CDRH Division of Standards and Conformity Assessment - ASCA Program, FDA



Director of Conformity Assessment Program, FDA
Eric Franca received his PhD in Biomedical Engineering from the University of Florida where he investigated novel carbon nanomaterials for developing more effective neural electrodes. He began his professional career as a lead reviewer of medical devices at the Food and Drug Administration. He subsequently moved into a policy analyst position managing the content and publication of guidances, orders, and regulations related to medical device review and CDRH policies. He currently serves as Director of the Conformity Assessment Program in his role as an Assistant Director in CDRH’s Division of Standards and Conformity Assessment. Concurrent with his work as a regulator within the FDA, Dr. Franca has participated in standards development, serving in leadership positions within the US National Committee to the IEC and as an US technical expert on several standard development committees.
MPM, Regulatory Policy Analyst, CDRH Division of Standards and Conformity Assessment - ASCA Program, FDA
No bio provided

Principal Engineer in UL Solutions’ CMIT Business Unit, UL Solutions
Pamela Gwynn is a Principal Engineer in UL Solutions’ CMIT business unit, with global technical leadership responsibilities for Medical Electrical Equipment (IEC/UL 60601 and 80601 series), Personal Health and Hygiene Appliances, and a broad range of healthcare‑related technologies. With more than 38 years of experience in product safety, Pamela brings deep expertise in medical electrical devices, home healthcare products, and household appliance categories—offering a uniquely comprehensive perspective on emerging consumer‑health technology.
Pamela was inducted in 2023 as a UL Corporate Fellow within the William Henry Merrill Society—the highest lifetime recognition awarded by UL Solutions for distinguished technical achievement and contributions to public safety. As a Corporate Fellow, she provides strategic engineering and scientific guidance in areas including research, technical workforce development, mentorship, and stewardship of UL’s technical legacy.

Co-Chair and Vice-President, RAPS North Carolina Local Networking Group
Rohan Shah is the Associate Director of Regulatory Affairs Advanced Repair and Reconstructions, Surgery at BD (Becton, Dickinson and Company), with a broad cross-functional background in Medical Devices spanning over 18 years.
Rohan has deep experience across high‑risk implantable products and innovation programs. He has held regulatory roles of increasing responsibility, bringing a strong understanding of EU MDR, FDA pathways, clinical evidence, and post‑market requirements to enable efficient and compliant global market access.
Rohan’s regulatory career was shaped by formative early years in R&D and product development at Covidien and Teleflex, where he worked across technology development, design controls, and manufacturing transfer. His transition into Regulatory Affairs began at the BSI Notified Body, where he served in technical and scheme leadership roles—experience that continues to inform his patient safety and clinical efficacy approach to regulatory strategy.
Rohan holds a Bachelors of Science in Biomedical Engineering from The City College of New York and a Masters in Science from The University of Connecticut.